Abstract
The pathophysiology of endotoxic shock is complex. This review emphasizes the role of reactive oxygen species (ROS) in the pathophysiology of endotoxic shock and the effectiveness of flaxseed in amelioration of the deleterious effects of endotoxic shock on the cardiovascular function and health of the tissue. Endotoxic shock is associated with reduction in the cardiac function measured by cardiac index and left ventricular work index, cardiac contractility measured by dp/dt (rate of change of left ventricular pressure development), dp/dt at CPIP/PAW, where CPIP is common peak isovolumetric pressure and PAW is pulmonary arterial wedge pressure, arterial pressure, and cellular damage measured by increased plasma creatine kinase and elavated plasma lactate. It is also accompanied by increases in the generation of ROS by polymorphonuclear leukocytes, and cardiac lipid peroxidation product malondialdehyde (MDA) (cardiac MDA) and reduction in antioxidant reserve and antioxidant enzyme activity. Dimethylthiourea an antioxidant, prevented/reduced the endotoxic shock-induced changes in the cardiac function and contractility, arterial pressure, ROS generated by polymorphonuclear leucocytes; MDA, antioxidant reserve and antioxidant enzyme activity of cardiac tissue, and cellular health. Flaxseed which has antioxidant component ameliorated the endotoxic shock-induced changes in the cardiac function and contractility, arterial pressure, oxidative stress parameters and cellular health. In conclusion, the data suggest that ROS may play a role in the pathophysiology of endotoxic shock and that flaxseed, an antioxidant may have a role in the treatment of endotoxic shock.
Keywords: Flaxseed, reactive oxygen species, antioxidant, dimethylthiourea, endotoxic shock, cardiac function, cardiac contractility, arterial pressure, antioxidant reserve, antioxidant enzymes, creatine kinase, lactate.
Current Pharmaceutical Design
Title:Flaxseed and Endotoxic Shock
Volume: 20 Issue: 9
Author(s): Kailash Prasad
Affiliation:
Keywords: Flaxseed, reactive oxygen species, antioxidant, dimethylthiourea, endotoxic shock, cardiac function, cardiac contractility, arterial pressure, antioxidant reserve, antioxidant enzymes, creatine kinase, lactate.
Abstract: The pathophysiology of endotoxic shock is complex. This review emphasizes the role of reactive oxygen species (ROS) in the pathophysiology of endotoxic shock and the effectiveness of flaxseed in amelioration of the deleterious effects of endotoxic shock on the cardiovascular function and health of the tissue. Endotoxic shock is associated with reduction in the cardiac function measured by cardiac index and left ventricular work index, cardiac contractility measured by dp/dt (rate of change of left ventricular pressure development), dp/dt at CPIP/PAW, where CPIP is common peak isovolumetric pressure and PAW is pulmonary arterial wedge pressure, arterial pressure, and cellular damage measured by increased plasma creatine kinase and elavated plasma lactate. It is also accompanied by increases in the generation of ROS by polymorphonuclear leukocytes, and cardiac lipid peroxidation product malondialdehyde (MDA) (cardiac MDA) and reduction in antioxidant reserve and antioxidant enzyme activity. Dimethylthiourea an antioxidant, prevented/reduced the endotoxic shock-induced changes in the cardiac function and contractility, arterial pressure, ROS generated by polymorphonuclear leucocytes; MDA, antioxidant reserve and antioxidant enzyme activity of cardiac tissue, and cellular health. Flaxseed which has antioxidant component ameliorated the endotoxic shock-induced changes in the cardiac function and contractility, arterial pressure, oxidative stress parameters and cellular health. In conclusion, the data suggest that ROS may play a role in the pathophysiology of endotoxic shock and that flaxseed, an antioxidant may have a role in the treatment of endotoxic shock.
Export Options
About this article
Cite this article as:
Prasad Kailash, Flaxseed and Endotoxic Shock, Current Pharmaceutical Design 2014; 20 (9) . https://dx.doi.org/10.2174/13816128113199990557
DOI https://dx.doi.org/10.2174/13816128113199990557 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Tuberculosis Prevention, Diagnosis and Drug Discovery"
The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
Melanoma and Non-Melanoma Skin Cancer Treatment: Standard of Care and Recent Advances
In this thematic issue, we aim to provide a standard of care of the diagnosis and treatment of melanoma and non-melanoma skin cancer. The editor will invite authors from different countries who will write review articles of melanoma and non-melanoma skin cancers. The Diagnosis, Staging, Surgical Treatment, Non-Surgical Treatment all ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Blocking the Path to Death: Anti-Apoptotic Molecules in Ischemia /Reperfusion Injury of the Liver
Current Pharmaceutical Design Roles of Secreted Phospholipases A<sub>2</sub> in the Mammalian Immune System
Protein & Peptide Letters HSP60 as a Drug Target
Current Pharmaceutical Design Regulation of Myocardial Extracellular Matrix Dynamic Changes in Myocardial Infarction and Postinfarct Remodeling
Current Cardiology Reviews Beneficial Effects of Statins on Endothelial Dysfunction and Vascular Stiffness
Current Vascular Pharmacology Role of Nitric Oxide in the Modulation of Angiogenesis
Current Pharmaceutical Design Understanding Stem Cell-Mediated Brain Repair Through Neuroimaging
Current Stem Cell Research & Therapy Editorial (Hot Topic: Novel Biomarkers in the Prognosis, Progression and Treatment of Cardiovascular Disease: The Role of microRNAs )
Current Topics in Medicinal Chemistry Pleiotropic Effects of Nicotinic Acid: Beyond High Density Lipoprotein Cholesterol Elevation
Current Vascular Pharmacology Use of Recombinant Factor VII in Cardiac Surgery
Recent Patents on Cardiovascular Drug Discovery Proteasomal Inhibition: A Novel Pathway for Prevention of Atherosclerosis and Restenosis
Vascular Disease Prevention (Discontinued) Recent Patents Concerning Modulators of Protein Kinase C
Recent Patents on DNA & Gene Sequences Use of Corticosteroids in Critically Ill Septic Patients: A Review of Mechanisms of Adrenal Insufficiency in Sepsis and Treatment
Current Drug Targets CD93: Recent Advances and Implications in Disease
Current Drug Targets The Role of Annexin A1 and Formyl Peptide Receptor 2/3 Signaling in Chronic Corticosterone-Induced Depression-Like behaviors and Impairment in Hippocampal-Dependent Memory
CNS & Neurological Disorders - Drug Targets Cardioprotective Utility of Urocortin in Myocardial Ischemia- Reperfusion Injury: Where do We Stand?
Current Molecular Pharmacology C-Reactive Protein and Asymmetric Dimethylarginine: Markers or Mediators in Cardiovascular Disorders?
Current Pharmaceutical Design Critical Questions for Preclinical Trials on Safety and Efficacy of Vascular Endothelial Growth Factor-Based Therapeutic Angiogenesis for Ischemic Stroke
CNS & Neurological Disorders - Drug Targets Training Standards and Recommendations for Intervention on Chronic Total Occlusions
Current Cardiology Reviews Antivitamin K Drugs in Stroke Prevention
Current Vascular Pharmacology